Ask the Expert Q&A
Mature Mood Matters: New and Emerging Developments in Geriatric Depression
neuroscienceCME Webcast
Premiere Date: Wednesday, August 21, 2013This activity offers CE credit for:
- Physicians (CME)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, August 21, 2014
Note: Credit Is No Longer Available
 | Charles F. Reynolds, III, MD UPMC Endowed Professor in Geriatric Psychiatry University of Pittsburgh School of Medicine Professor of Behavioral and Community Health Sciences Graduate School of Public Health Pittsburgh, PA |
The American Association for Geriatric Psychiatry (AAGP) and CME Outfitters, LLC, conducted a satellite symposium entitled, Mature Mood Matters: New and Emerging Developments in Geriatric Depression at the AAGP Annual Meeting on March 15, 2013. The activity was attended by geriatric psychiatrists and psychiatrists with an interest in geriatric depression and focused on three timely topics: (1) implications for measurement-based care in geriatric depression from the recently released fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5); (2) the updated Beers Criteria released in 2012 by the American Geriatrics Society that focus on use of potentially inappropriate medications (PIMs) in older adults; and (3) therapeutic advances in the treatment of geriatric depression.
This live, interactive symposium was captured on video and is available as a certified activity at www.neuroscienceCME.com/CM786 and www.aagponline.org.
Because the opportunity to engage and connect with faculty is critical physician learning, a companion live Q & A has been scheduled to “Ask the Expert” about content presented during the symposium on Wednesday, August 21, 2013.
During this activity, you will be able to ask questions, discuss your clinical case successes and challenges; and gain insight and practice pearls from Charles F. Reynolds, III, MD. Please register in advance for this live Q & A session. It is an activity that you don’t want to miss.
To educate on new and emerging developments in geriatric depression regarding how they influence the clinical practice of geriatric psychiatry.
At the end of this CE activity, participants should be able to:
- Apply guidance about potentially inappropriate medications (PIMs) from the updated Beers Criteria to their prescribing practices in older adults with geriatric depression and common comorbidities.
- Review DSM-5 revisions and their potential impact on the clinical management of geriatric depression, especially in terms of promoting measurement-based care.
- Increase the percentage of patients with geriatric depression who are reassessed using a quantitative assessment tool within three months of initiating treatment.
Provided by the American Association for Geriatric Psychiatry. Supported by Forest Research Institute, Inc., a wholly-owned subsidiary of Forest Laboratories Inc.
Physicians and other healthcare professionals who care for geriatric patients with depression.
CME Credit (Physicians):
The American Association for Geriatric Psychiatry (AAGP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Association for Geriatric Psychiatry (AAGP) designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST786 (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Policy on privacy and confidentiality:
Click here to view AAGP’s privacy and confidentiality policy.
Copyright: The American Association for Geriatric Psychiatry owns the copyright for this material or has obtained permission to distribute this material from all speakers.
Disclosure of Relevant Financial Relationships with Commercial Interests
American Association for Geriatric Psychiatry (AAGP) and CME Outfitters, LLC, adhere to the ACCME Standards regarding commercial support of continuing medical education. It is the policy of AAGP and CME Outfitters, LLC, that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
A conflict of interest is created when individuals in a position to control the content of CME have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
AAGP and CME Outfitters will identify, review, and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relevant financial relationships exist between the following individuals and commercial interests:
Dr. Reynolds has disclosed that he has received research support from American Association of Geriatric Psychiatry-Editorial Review Board Fee; Grants support from National Institute of Health (NIH): National Institute of Mental Health (NIMH); National Institute on Aging (NIA); National Institute on Minority Health and Health Disparities (NIMHD); National Heart, Lung, and Blood Institute (NHLBI); Centers for Medicare & Medicaid Services (CMS); John A. Hartford Foundation; American Foundation for Suicide Prevention; Commonwealth of Pennsylvania; Patient-Centered Outcomes Research Institute (PCORI); American Association for Geriatric Psychiatry (AAGP)-Associate Editor; Bristol-Meyers Squibb Company, Forrest Labs; Eli Lilly and Company; Pfizer Inc.-Provides pharmaceutical supplies for NIH-sponsored work. (The pharmaceutical companies play no role in the design, analysis, or reporting of my data in peer reviewed journals.) He is a Licensed Intellectual Property (co-inventor) Psychometric analysis of the Pittsburgh Sleep Quality Index (PSQI) PRO10050447, PI: Dr. Daniel Buysse.
Christine M. deVries (AAGP staff - planning committee) has nothing to disclose
Marjorie Vanderbilt (AAGP staff - planning committee) has nothing to disclose
Daniel Bateman, MD (content/peer reviewer) has nothing to disclose.
David Beck, MD (content/peer reviewer) has nothing to disclose.
Tatyana P. Shteinlukht, MD, PhD (content/peer reviewer) has nothing to disclose.
Monique Johnson, MD, CCMEP (planning committee) has nothing to disclose.
Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has nothing to disclose.
Sandra Haas Binford, MAEd (planning committee) has nothing to disclose.
Sharon Tordoff, CCMEP (planning committee) has nothing to disclose.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
AAGP, CME Outfitters, LLC, the faculty, and Forest Laboratories do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
WC-022-082113-03
